Vivos Inc RDGL
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.10
- Day Range
- $0.10–0.11
- 52-Week Range
- $0.04–0.12
- Bid/Ask
- $0.10 / $0.11
- Market Cap
- $41.33 Mil
- Volume/Avg
- 1.4 Mil / 828,342
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1,945.28
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Vivos Inc is a radiation oncology medical device company. It is engaged in the development of RadioGel which is a brachytherapy device comprising highly insoluble particles delivered by needle injection using a water-polymer composite for high-dose treatment of non-resectable solid tumors. IsoPet is another product of the company used for the treatment of solid tumors in animals. The company derives revenue through sales of its products.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- —
- Total Number of Employees
- 1
- Website
- https://www.radiogel.com
Valuation
|
Metric
|
RDGL
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 1,945.28 |
Price/Cash Flow | — |
Price/Earnings
RDGL
Financial Strength
|
Metric
|
RDGL
|
|---|---|
Quick Ratio | 6.53 |
Current Ratio | 6.57 |
Interest Coverage | — |
Quick Ratio
RDGL
Profitability
|
Metric
|
RDGL
|
|---|---|
Return on Assets (Normalized) | −167.89% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −184.37% |
Return on Assets
RDGL
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Zhmlgrhb | Gwrzrdz | $182.7 Bil | |
SYK
| Stryker Corp | Grnsyzmhdj | Fhsvb | $124.6 Bil | |
MDT
| Medtronic PLC | Lztrzgy | Vrjxdx | $105.2 Bil | |
BSX
| Boston Scientific Corp | Kdjsgny | Tjnkqjm | $99.1 Bil | |
EW
| Edwards Lifesciences Corp | Qrgscprdl | Zglyr | $52.0 Bil | |
DXCM
| DexCom Inc | Lrmnzcyrx | Mkpl | $51.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Ydtvmdts | Lmxfn | $24.5 Bil | |
ALGN
| Align Technology Inc | Hpzsmbym | Jrsssxl | $22.7 Bil | |
PHG
| Koninklijke Philips NV ADR | Hrgsdpj | Kwxwfy | $18.3 Bil | |
PODD
| Insulet Corp | Pkylrdwhz | Xvqytmk | $11.6 Bil |